Authors: Liu Yuting, Zhang Hong DOI: 10.3760/cma.j.cn115989-20190325-00141 Published 2022-08-10 Cite asChin J Exp Ophthalmol, 2022, 40(8): 781-784. Abstract [View PDF] [Read Full Text] Cytomegalovirus is a kind of double-stranded DNA virus in herpesvirus family.The initial infection can occur at all ages.The ocular manifestations are […]
Tag: Uveitis
Pay attention to the risk of infection and tumor progression during application of TNF-α inhibitors in uveitis
Authors: Chi Ying, Yang Liu DOI: 10.3760/cma.j.cn115989-20211020-00571 Published 2021-11-10 Cite asChin J Exp Ophthalmol, 2021, 39(11): 929-932. Abstract [View PDF] [Read Full Text] Adalimumab, one of the tumor necrosis factor-α (TNF-α) inhibitors, has been approved as a therapeutic drug for non-infectious intermediate, posterior and pan-uveitis […]
Role of IL-23/IL-17 pathway and regulatory network in the pathogenesis of uveitis
Authors: Yi Shenglan, Yang Peizeng DOI: 10.3760/cma.j.cn115989-20191119-00500 Published 2021-11-10 Cite asChin J Exp Ophthalmol, 2021, 39(11): 1010-1016. Abstract [View PDF] [Read Full Text] Uveitis is an inflammatory disease, a leading cause of blindness, the pathogenesis of which is not fully understood.In recent years, it has […]
Specialized proresolving lipid mediators and eye diseases
Authors: Zhu Yingting, Li Yiqing, Zhuo Yehong DOI: 10.3760/cma.j.cn115989-20200607-00402 Published 2021-07-10 Cite asChin J Exp Ophthalmol, 2021, 39(7): 649-654. Abstract [View PDF] [Read Full Text] Novel endogenous lipid-mediated molecules including lipoxins, resolvins, protectins, and maresin families are discovered recently and are collectively called specialized proresolving […]
Changes of peripheral blood leukocyte in Behçet uveitis patients with different stages
Authors: Liu Xinshu, Huang Chunmei, Li Yongzhe, Zhang Meifen DOI: 10.3760/cma.j.issn.2095-0160.2019.12.007 Published 2019-12-10 Cite as Chin J Exp Ophthalmol, 2019,37(12): 971-975. Abstract [View PDF] [Read Full Text] Objective To analyze the changes of peripheral blood leukocyte in patients with Behçet uveitis (BU) at different stages. Methods […]
Current surgical management approaches for uveitic glaucoma
Authors: Xiao Junyan, Zhang Meifen DOI: 10.3760/cma.j.issn.2095-0160.2019.10.014 Published 2019-10-10 Cite as Chin J Exp Ophthalmol, 2019,37(10): 839-842. Abstract [View PDF] [Read Full Text] Glaucoma is a potentially blinding complication of uveitis.Management of uveitic glaucoma remains challenging.Vision can be partly recovered if correct diagnosis and timely treatment are […]
Progress and prospect of treatment for ocular Behçet disease
Authors: Bai Lin, Yang Peizeng DOI: 10.3760/cma.j.issn.2095-0160.2016.08.020 Published 2016-08-10 Cite as Chin J Exp Ophthalmol, 2016,34(8): 761-764. Abstract [Download PDF] [Read Full Text] Ocular Behçet disease, which usually presents as panuveitis, with characteristic of vision impairment and relapse, is one of the most refractory uveitis entities.Usually, one […]
The pathological mechanism and clinical research of dendritic cells in the uveitis
Authors: Wang Beibei, Lin Wei, Bi Hongsheng DOI: 10.3760/cma.j.issn.2095-0160.2016.08.019 Published 2016-08-10 Cite as Chin J Exp Ophthalmol, 2016,34(8): 756-760. Abstract [Download PDF] [Read Full Text] Uveitis is mainly T helper cells (Th)-mediated autoimmune disease.It is one of the common eye diseases causing blindness.Dendritic cells (DCs), which are […]
The dynamic changes of regulatory T cells in the pathogenesis of experimental autoimmune uveitis
Authors: Zhang Lian, Song Jike, Tang Kai, Zheng Fengming, Guo Junguo, Bi Hongsheng DOI: 10.3760/cma.j.issn.2095-0160.2016.08.003 Published 2016-08-10 Cite as Chin J Exp Ophthalmol, 2016,34(8): 684-690. Abstract [Download PDF] [Read Full Text] Background Studies show that regulatory T cells (Treg) are a kind of T cell subsets to […]
Clinical characteristics of pediatric ocular toxocariasis
Authors: Liu Jinghua, Li Songfeng, Deng Guangda, Li Liang, Ma Jing, Ma Yan, Lu Hai DOI: 10.3760/cma.j.issn.2095-0160.2019.05.011 Published 2019-05-10 Cite as Chin J Exp Ophthalmol, 2019,37(5): 371-375. Abstract [View PDF] [Read Full text] Objective To describe the clinical manifestations of […]